These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6048655)

  • 21. [Attempt at intermittent chemotherapeutic treatment of patients with bacilli resistant to streptomycin and isoniazid (cooperative survey by the antitubercular services of Marrakech, Meknes, Tangiers)].
    Burzoni FJ; Chicou FJ; Durante C; Hetrick G; Ras R
    Rev Tuberc Pneumol (Paris); 1969 Nov; 33(7):975-86. PubMed ID: 5403000
    [No Abstract]   [Full Text] [Related]  

  • 22. Position of cycloserine in the treatment of pulmonary tuberculosis.
    Meyer A; Nadjar G
    Scand J Respir Dis Suppl; 1970; 71():139-43. PubMed ID: 5271974
    [No Abstract]   [Full Text] [Related]  

  • 23. [EFFECTS OF ETHIONAMIDE ON TUBERCLE BACILLI RESISTANT TO VARIOUS ANTITUBERCULAR AGENTS AND THE EFFECTS OF THESE AGENTS ON ETHIONAMIDE-RESISTANT TUBERCLE BACILLI].
    TSUCHIMOCHI T
    Kekkaku; 1963 Jun; 38():264-9. PubMed ID: 14046673
    [No Abstract]   [Full Text] [Related]  

  • 24. Limitations of the clinical activity of cycloserine therapy. Appearance of resistance to cycloserine when used alone and in combination with other drugs.
    Molina C
    Scand J Respir Dis Suppl; 1970; 71():296-305. PubMed ID: 5272000
    [No Abstract]   [Full Text] [Related]  

  • 25. [Cases of pulmonary tuberculosis in which kanamycin-resistant tubercle bacilli did not appear even after a long-term administration of kanamycin. Some consideration on the interpretation of drug resistance tests].
    Tsukamura M
    Kekkaku; 1971 Oct; 46(10):405-8. PubMed ID: 4112456
    [No Abstract]   [Full Text] [Related]  

  • 26. [Evolution of antibiograms of bacilli persisting under treatment in the sanatorium].
    Marion L
    Rev Tuberc Pneumol (Paris); 1967; 31(6):785-808. PubMed ID: 4317451
    [No Abstract]   [Full Text] [Related]  

  • 27. Technical and bacteriological aspects of a continuous survey of drug resistance in tuberculosis in South Africa.
    De ville de Goyet CA; Kleeberg HH
    Tubercle; 1972 Mar; 53(1):9-26. PubMed ID: 4114098
    [No Abstract]   [Full Text] [Related]  

  • 28. Results of treatment of patients with pulmonary tuberculous with a combination of cycloserine and other tuberculostatics.
    Raboukhine A
    Scand J Respir Dis Suppl; 1970; 71():155-8. PubMed ID: 5271977
    [No Abstract]   [Full Text] [Related]  

  • 29. Experience with cycloserine.
    Dissmann E
    Scand J Respir Dis Suppl; 1970; 71():239-43. PubMed ID: 5317744
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of chronic polyresistant pulmonary tuberculosis using ethionamide, pyrazinamide and cycloserine].
    Sighart H; Opl G
    Prax Pneumol; 1968 Nov; 22(11):692-8. PubMed ID: 5714048
    [No Abstract]   [Full Text] [Related]  

  • 31. Ethambutol in re-treatment of pulmonary tuberculosis.
    Am Rev Respir Dis; 1968 Nov; 98(5):825-36. PubMed ID: 4300827
    [No Abstract]   [Full Text] [Related]  

  • 32. [On qualitative demonstration of tuberculostatics in the control of taking of drugs].
    Grunert M; Reutgen H; Iwainsky H
    Z Tuberk Erkr Thoraxorg; 1965; 124(3):141-8. PubMed ID: 5899136
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical evaluation of intolerance to cycloserine.
    Baroni V; Foddai G; Lukinovich N; Pontiggia P
    Scand J Respir Dis Suppl; 1970; 71():217-9. PubMed ID: 4318440
    [No Abstract]   [Full Text] [Related]  

  • 34. CHEMOTHERAPY FOR PATIENTS WITH CULTURES RESISTANT TO STREPTOMYCIN, ISONIAZID AND PAS.
    JANCIK E; ZELENKA M; TOUSEK J; MAKOVA M
    Tubercle; 1963 Dec; 44():443-5. PubMed ID: 14101324
    [No Abstract]   [Full Text] [Related]  

  • 35. The problem of the chronic excretor of tubercle bacilli.
    Stýblo K; Kubík A; Langerová M; Matusková E; Morávková K
    Scand J Respir Dis; 1968; 49(3):236-48. PubMed ID: 4309247
    [No Abstract]   [Full Text] [Related]  

  • 36. Should isoniazid be used in retreatment of tuberculosis despite acquired isoniazid resistance?
    Moulding TS
    Am Rev Respir Dis; 1981 Mar; 123(3):262-4. PubMed ID: 6784621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Internal medicine treatment of pulmonary tuberculosis].
    Schaich W
    Med Klin; 1970 Sep; 65(36):1553-8. PubMed ID: 4995072
    [No Abstract]   [Full Text] [Related]  

  • 38. D-CYCLOSERINE IN THE TREATMENT OF PULMONARY TUBERCULOSIS RESISTANT TO THE STANDARD DRUGS: A STUDY OF 116 CASES.
    RUIZ RC
    Dis Chest; 1964 Feb; 45():181-6. PubMed ID: 14115734
    [No Abstract]   [Full Text] [Related]  

  • 39. [Therapy of pulmonary tuberculosis in its current aspects].
    Gartmann JC
    Bibl Tuberc; 1965; 20():59-70. PubMed ID: 4291161
    [No Abstract]   [Full Text] [Related]  

  • 40. A comparison of ethionamide-cycloserine and ethionamide-pyrazinamide regimens in patients resistant to major chemotherapeutics.
    Vidinel I
    Scand J Respir Dis Suppl; 1970; 71():192-5. PubMed ID: 5271985
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.